A blood pressure (BP) difference between arms was first reported over 100 years ago. Knowledge of its prevalence and relevance to the accurate measurement of BP remains poor. Current hypertension guidelines do not emphasise it. The objectives of this study were to establish the best estimate of prevalence of the interarm difference (IAD) in the population, to consider its implications for accurate BP measurement and treatment, and to discuss its aetiology and potential as a risk marker for cardiovascular disease. Systematic literature review was carried out. The data sources were Medline EMBASE and CINAHL databases, and Index of Theses. Studies reporting prevalence rates of IAD were retrieved and considered for inclusion against explicit methodological criteria. Point prevalence rates were extracted and weighted mean prevalence rates calculated. The main outcome measures were weighted mean prevalences of systolic IADX10 and X20 mm Hg and of diastolic IADX10 mm Hg. Thirty-one studies were identified. Most had methodological weaknesses; only four met the inclusion criteria. Pooled prevalences of the IAD from these four studies were 19.6% systolic X10 mm Hg (95% CI 18.0-21.3%), 4.2% systolic X20 mm Hg (95% CI 3.4-5.1%) and 8.1% diastolic X10 mm Hg (95%CI 6.9-9.2%). In conclusion, an IAD is present in a substantial number of patients and should be looked for whenever diagnosis and treatment depend on accurate measurements of BP. The importance of an IAD should be better emphasised in current hypertension management guidelines. There is evidence associating an IAD with peripheral vascular disease, raising the possibility that its presence may predict cardiovascular events.
Introduction
Patients are regularly encountered in the clinical setting with a different systolic or diastolic blood pressure (BP) in each arm. Comparisons of arm pressures have been made ever since the modern sphygmomanometer was introduced, 1 yet the significance of this finding, which Cyriax named the 'differential BP sign', 2 is still poorly appreciated today.
Hypertension is one of the major causes of premature morbidity and mortality throughout the developed and developing worlds. 3 The vast majority of patients with hypertension are managed in primary care 4 and measurement of BP is the most common investigation performed in this setting. 5 The management of hypertension is known to be suboptimal; 6 therefore, knowledge of the latest guidelines, and the many factors known to influence readings, is crucial. 7 The prevalence of a systolic (sIAD) or a diastolic (dIAD) inter-arm difference, its importance for the management of hypertension, its significance as a potential marker of peripheral vascular disease (PVD) and predictor of cardiovascular disease (CVD) in hypertensive patients are the subjects of this review.
Although recent ambulatory BP monitoring guidelines recommend routine bilateral assessment, 8 the latest British guidelines for the management of hypertension merely state that 'BP should initially be measured in both arms as patients may have large differences (410 mm Hg) between arms. The arm with the higher values should be used for subsequent measurements ' . 9 This appears to be guidance repeated almost verbatim through previous versions [10] [11] [12] [13] [14] stretching back over 60 years. 15 The guidelines do not consider the prevalence of the IAD and suggest that differences X20 mm Hg systolic and/or 10 mm Hg diastolic warrant specialist referral. 16 As only one in three measurements of BP in practice are made according to guidelines, 17, 18 it is unlikely that even this passing reference to an IAD is acted upon. The latest Joint National Committee guidelines (JNC VII) merely suggest BP 'verification in the contralateral arm'. 19 Appreciation of the presence and implications of an IAD is clearly vital for accurate diagnosis and consistent management of hypertension. Following an earlier small study of a mixed normotensive and hypertensive cohort of primary care patients, we proposed that the IAD may be caused by PVD. 20 As PVD is itself a strong predictor of CVD, [21] [22] [23] [24] [25] [26] the recognition of the IAD as a sign of PVD would suggest that the IAD may also have prognostic value as a marker for predicting cardiovascular events in a similar manner to a reduced ankle-brachial pressure index (ABPI). ABPI measurement has been proposed as a screening test, 27 but is not routinely undertaken in the general practice assessment of hypertensive patients in the United Kingdom. It is time consuming and requires specialised equipment and a degree of training, whereas bilateral brachial BP measurements are easily taken and are in any case recommended in the assessment of new hypertensive patients. 9 In symptomatic chronic upper limb ischaemia, where the IAD is marked, 28 the predominant cause is atherosclerosis (Table 1) , and this is associated with PVD. 29 It therefore seems logical that the causes of an asymptomatic IAD should be similar. Consequently, the recognition of an IAD could have value in providing a simple screening test to apply in routine consultations to identify patients potentially at the highest risk of cardiovascular events and therefore in need of further assessment. This would facilitate more appropriate targeting of limited resources in primary prevention, as required by the National Service Framework for Coronary Heart Disease (CHD). 30 31 have been cited in the Discussion.
Methods

Identification of studies
Selection and quality assessment of studies Cross-sectional or cohort studies reporting a prevalence figure for sIAD or dIAD were retrieved for assessment. Reports meeting the predefined quality criteria based on sample selection, sample size and method of measurement of the IAD (Box 1) were included in the analysis.
Data collection and synthesis
The principal investigator extracted data on prevalence rates, study population and methods of measurement from all studies reporting prevalences of the IAD. Where possible data were combined to derive pooled estimates of prevalences and magnitudes of sIAD and dIAD using weighted means and standard errors. 32 
Results
Searches identified 357 citations, from which 18 articles were retrieved. Hand searching of references identified a further 19 older papers. After exclusion of papers without prevalence data, only four papers met the inclusion criteria (Figure 1) .
Description of studies
All potential studies for inclusion were crosssectional studies reporting point prevalences of and older studies tended to report highly selected series. 34, 36, [41] [42] [43] [44] [45] Others suffered from bias in the selection of results for analysis 37, 46 or reported small sample sizes (defined as o100 subjects). 
Reported prevalences
Only four studies met the inclusion criteria 37, 51, 52, 60 ( Table 2 ). The mean prevalences of sIAD in these studies were 19.6%X10 mm Hg (95% CI 18.0-21.3%) and 4.2%X20 mm Hg (95% CI 3.4-5.1%) and for dIAD 8.1%X10 mm Hg (95% CI 6.9-9.2%). The mean prevalences for excluded studies were significantly higher (Table 3) . One study presented data for normotensive and hypertensive subjects, 60 the prevalences of sIADX20 mm Hg and 
Discussion
The prevalence rates presented demonstrate that the IAD is a common finding in clinical practice whenever it is looked for. The majority of reports and all included studies was from selected or secondary care populations, the true general population or primary care prevalence is unknown. Studies using sequential or single pair measurement techniques appear to overestimate prevalence compared with studies meeting our inclusion criteria.
Strengths and weaknesses of the review
Published data on the prevalence of an IAD stretch back to 1900. 61 Thorough hand searching appears to have yielded as full a set of papers as possible, but as only English language papers were retrieved some data may have been excluded. No foreign language citations were identified after 1929; 62 therefore, it seems unlikely that our findings could have been substantially altered by their inclusion. Data extraction was only carried out by one investigator but was not a complex task, and the inclusion criteria were clear and objective. The choices of inclusion criteria were our own but based on a published critique 32 of the methodology of one of the studies. 46 Implications for BP measurement in practice Failure to recognise the IAD and to standardise readings to the higher arm runs the risks of inadequate treatment of hypertensive patients, false diagnosis of hypotension due to over treatment (pseudohypotension 36 ), a delay in the diagnosis of hypertension, 63 or physician confusion creating the potential for 'clinical inertia'. 64 The Health Survey of England states that 'if systolic BP were lowered by X10 mm Hg among the 71.5% of hypertensive subjects uncontrolled (in the survey), we estimate that 44000 fatal and nonfatal coronary events and 46000 fatal and nonfatal strokes could be prevented each year in England.' 6 Given our estimate of the prevalence of a sIADX10 mm Hg of 19.6%, there is a one in 10 risk that a BP measurement could be underestimated by this amount if the IAD has not been excluded. We suggest that it is vital to undertake measurements of BP in a consistent manner in both arms for all subjects, to record the findings accurately, and to record measurements taken from the 'higher arm' to guide subsequent assessments. This approach should be more clearly emphasised in future hypertension guidelines, and given the prevalence figures that we have presented, the advice to refer subjects with a sIAD X20 mm Hg or dIAD X10 mm Hg for specialist assessment is seen to be impractical and should be revised.
Pathophysiology of the IAD
Although the ability of arteriosclerosis to affect BP has long been recognised 65 and the presence of an IAD is used to help diagnose symptomatic upper limb ischaemia, 28 in health it has historically been dismissed as a normal variant. Anatomical explanations have been proposed 31, 39, 49, 53, 60, 66 but there is now evidence for an association with PVD, suggesting a pathological rather than a physiological aetiology.
Initially the IAD was described as a sign of aortic aneurysm 67 or vascular disease, 68, 69 and the earliest report dismissed its magnitude in health as negligible, with differences of 10 mm Hg being unusual. 61 The earliest series of 36 patients reported a pressure difference of 10 mm Hg or more in 20%, leading to the conclusion that 'the difference between the right and left brachial arteries is by no means diagnostic of aneurysm'. 70 Another early series of 100 healthy subjects found only 10% to have equal BPs 71 and the argument against arteriosclerosis as a cause ever since has been that these differences are too frequent, 37 and therefore represent a spectrum of normality. Consequently, anatomical explanations were advanced, which considered the angulation and anatomy of the aortic arch and its branches. 31, 39, 49, 53, 60, 66 The high prevalence of an IAD in war victims with unilateral injuries seemed to support this explanation. 35 But normal anatomy alone cannot explain the higher left arm pressures noted. 36, 51 It is our contention that the IAD may be due Abbreviations: CI, confidence interval; dIAD, diastolic inter-arm difference; sIAD, systolic inter-arm difference.
The inter-arm blood pressure difference CE Clark et al to occult PVD 59 and one recent study of subclavian artery stenosis has shown such an association. 29 If indeed such an observation was confirmed, one would predict that factors associated with PVD should have a higher prevalence in patients with an IAD. CHD is one common condition strongly associated with PVD, as defined by a reduced ABPI. [21] [22] [23] [24] [25] 72 No study has set out to compare the prevalence of an IAD in patients with or without CHD; however, data extracted from one study meeting our inclusion criteria showed a significantly higher prevalence of sIADX10 mm Hg in patients with CVD than without (19.4 vs 2.7%; OR 4.34, 95% CI 2.09-9.04; Po0.0001).
52 Arteriosclerosis was also more common in subjects with an IAD in Kay and Gardner's study, 38 whereas although Singer and Hollander found no relationship between coronary risk factors and an IAD, they did find the mean sIAD to be significantly higher in patients with known coronary artery disease than without (14.5 vs 10.4 mm Hg; P ¼ 0.05). 55 Another smaller study reported higher prevalence of IAD in patients with PVD compared to both CHD patients and controls. 36 Thus, there is a body of indirect evidence to support our hypothesis.
There is also direct evidence from vascular studies. In one angiographic series, 83% of patients undergoing vascular surgery with a difference in systolic BPs had evidence of innominate or subclavian artery stenosis on the side with the lower BP. 73 IAD prevalence is also high (78-88%) in subclavian steal syndrome, 74, 75 and the severity of the stenosis has been associated with the size of the BP difference. 76 In another large series of patients presenting for coronary angiography, the non-simultaneously measured IAD had a low sensitivity and positive predictive value, but high specificity (85% for 410 mm Hg and 94% for X20 mm Hg) and negative predictive value (99% for 410 mm Hg and 98% for X20 mm Hg) for predicting subclavian stenosis, 77 and aortic arch angiography in a series of subjects with PVD showed a measurable stenosis of at least one brachiocephalic artery in 42% of 48 subjects studied. 78 Thus, there is evidence of an association of the IAD with symptomatic PVD. We propose that there is a similar underlying aetiology of asymptomatic arterial disease causing the IAD reported in these studies. As the risk of cardiovascular events is similarly high for subjects with symptomatic and asymptomatic PVD in primary care, 79 the recognition of the IAD, assuming our hypothesis to be correct, could become an important part of the risk assessment of hypertensive patients. This would facilitate the focusing of finite resources for primary prevention onto those at highest risk, as demanded by the National Service Framework for Coronary Heart Disease. 30 To justify this approach, evidence from prospective survival studies is needed. To date, only the authors have reported a correlation of reduced event-free survival with the IAD in a general 20 and hypertensive (Clark CE, MSc Dissertation, Peninsula Medical School, 2006) primary care population. Larger studies using careful and standardised bilateral assessments of BP are needed to confirm this important observation, and to examine the additional contribution as a risk factor that recognition of the IAD can make to cardiovascular risk assessment. Thus, Cyriax's words from 1921: 'Neglect to exclude the presence of the differential blood-pressure sign may easily lead to totally erroneous conclusions as to the state of the circulation' 33 remain just as relevant now.
Conclusions
The IAD has been repeatedly shown to occur in substantial numbers of patients studied in primary and secondary care, and needs to be looked for in all patients whose diagnosis and treatment depend on accurate BP measurements. Many studies have overestimated prevalence due to poor design, and our estimate of prevalence from good quality studies is 19.6% sIADX10 mm Hg, 4.3%X20 mm Hg and 8.1%X10 mm Hg dIAD. The prevalence in coronary heart disease and hypertensive patients appears to be much higher. This fact, and the importance of measuring both arms during assessment, should be better emphasised in current hypertension management guidelines.
There is a body of evidence associating the IAD with PVD, suggesting a pathological rather than physiological cause. This raises the possibility that the presence of the IAD may have a prognostic value in predicting cardiovascular events. There is preliminary evidence for this but further large, carefully controlled studies are needed to confirm it, and to establish what independent contribution to cardiovascular risk assessment the detection of an IAD may make.
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